Advertisement

Pflügers Archiv - European Journal of Physiology

, Volume 469, Issue 9, pp 1141–1149 | Cite as

Negligible effect of eNOS palmitoylation on fatty acid regulation of contraction in ventricular myocytes from healthy and hypertensive rats

  • Chun Li Jin
  • Yu Na Wu
  • Ji Hyun Jang
  • Zai Hao Zhao
  • Goo Taeg Oh
  • Sung Joon Kim
  • Yin Hua ZhangEmail author
Muscle Physiology
Part of the following topical collections:
  1. Muscle physiology

Abstract

S-palmitoylation is an important post-translational modification that affects the translocation and the activity of target proteins in a variety of cell types including cardiomyocytes. Since endothelial nitric oxide synthase (eNOS) is known to be palmitoylated and the activity of eNOS is essential in fatty acid-dependent β-oxidation in muscle, we aimed to test whether palmitoylation of eNOS is involved in palmitic acid (PA) regulation of left ventricular (LV) myocyte contraction from healthy (sham) and hypertensive (HTN) rats. Our results showed that PA, a predominant metabolic substrate for cardiac β-oxidation, significantly increased contraction and oxygen consumption rate (OCR) in LV myocytes from sham. Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME) or eNOS gene deletion prevented PA regulation of the myocyte contraction or OCR, indicating the pivotal role of eNOS in mediating the effects of PA in cardiac myocytes. PA increased the palmitoylation of eNOS in LV myocytes and depalmitoylation with 2-bromopalmitate (2BP; 100 μM) abolished the increment. Furthermore, although PA did not increase eNOS-Ser1177, 2BP reduced eNOS-Ser1177 with and without PA. Intriguingly, PA-induced increases in contraction and OCR were unaffected by 2BP treatment. In HTN, PA did not affect eNOS palmitoylation, eNOS-Ser1177, or myocyte contraction. However, 2BP diminished eNOS palmitoylation and eNOS-Ser1177 in the presence and absence of PA but did not change myocyte contraction. Collectively, our results confirm eNOS palmitoylation in LV myocytes from sham and HTN rats and its upregulation by PA in sham. However, such post-transcriptional modification plays negligible role in PA regulation of myocyte contraction and mitochondrial activity in sham and HTN.

Keywords

Cardiac myocyte Contraction eNOS Oxygen consumption Palmitic acid S-palmitoylation 

Notes

Compliance with ethical standards

Conflicts of interest

The authors declare that they have no conflicts of interest.

Sources of funding

This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013068067); by the Brain Korea 21 Graduate Programme of the Korean Ministry of Education, Science and Technology; Seoul National University Hospital; the Korean Society of Hypertension (2013); SK Telecom Research Fund (no. 3420130290); and from the National Natural Science Foundation of China (NSFC; 31460265).

References

  1. 1.
    Blakeman N, Weis M (2014). The interplay between eNOS palmitoylation and phosphorylation: the triacsin C effect. FASEB J 28 supplement 1075. 9 (abstract).Google Scholar
  2. 2.
    Davda D, El Azzouny MA, Tom CT, Hernandez JL, Majmudar JD, Kennedy RT, Martin BR (2013) Profiling targets of the irreversible palmitoylation inhibitor 2-bromopalmitate. ACS Chem Biol 8:1912–1917. doi: 10.1021/cb400380s CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Doenst T, Nguyen TD, Abel ED (2013) Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res 113:709–724. doi: 10.1161/CIRCRESAHA.113.300376 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Forrester MT, Hess DT, Thompson JW, Hultman R, Moseley MA, Stamler JS, Casey PJ (2011) Site-specific analysis of protein S-acylation by resin-assisted capture. J Lipid Res 52:393–398. doi: 10.1194/jlr.D011106 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Hamilton DJ, Zhang A, Li S, Cao TN, Smith JA, Vedula I, Cordero-Reyes AM, Youker KA, Torre-Amione G, Gupte AA (2016) Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure. Am J Physiol Heart Circ Physiol 310:H667–H680. doi: 10.1152/ajpheart.00746 CrossRefPubMedGoogle Scholar
  6. 6.
    He L, Kim T, Long Q, Liu J, Wang P, Zhou Y, Ding Y, Prasain J, Wood PA, Yang Q (2012) Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity. Circulation 126(14):1705–1716. doi: 10.1161/CIRCULATIONAHA.111. 075978 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Jin CZ, Jang JH, Kim HJ, Wang Y, Hwang IC, Sadayappan S, Park BM, Kim SH, Jin ZH, Seo EY, Kim KH, Kim YJ, Kim SJ, Zhang YH (2013) Myofilament Ca2+ desensitization mediates positive lusitropic effect of neuronal nitric oxide synthase in left ventricular myocytes from murine hypertensive heart. J Mol cell Cardiol 60:107-15 DIO:  10.1016/j.yjmcc.2013.04.017
  8. 8.
    Le Gouill E, Jimenez M, Binnert C, Jayet PY, Thalmann S, Nicod P, Scherrer U, Vollenweider P (2007) Endothelial nitric oxide synthase (eNOS) knockout mice have defective mitochondrial beta-oxidation. Diabetes 56:2690–2696. doi: 10.2337/db06-1228 CrossRefPubMedGoogle Scholar
  9. 9.
    Linder ME, Deschenes RJ (2007) Palmitoylation: policing protein stability and traffic. Nat Rev Mol Cell Biol 8:74–84. doi: 10.1038/nrm2084 CrossRefPubMedGoogle Scholar
  10. 10.
    Liu J, Garcia-Cardena G, Sessa WC (1996) Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry 35:13277–13281. doi: 10.1021/bi961720e CrossRefPubMedGoogle Scholar
  11. 11.
    Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC (2010) Myocardial fatty acid metabolism in health and disease. Physiol Rev 90:207–258. doi: 10.1152/physrev.00015.2009 CrossRefPubMedGoogle Scholar
  12. 12.
    Massion PB, Feron O, Dessy C, Balligand JL (2003) Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93:388–398. doi: 10.1161/01.RES.0000088351.58510.21 CrossRefPubMedGoogle Scholar
  13. 13.
    Pellieux C, Montessuit C, Papageorgiou I, Lerch R (2009) Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha. Cardiovasc Res 82:341–350. doi: 10.1093/cvr/cvp004 CrossRefPubMedGoogle Scholar
  14. 14.
    Zhao ZH, Jin CL, Jang JH, Wu YN, Kim SJ, Jin HH, Cui L, Zhang YH (2016) Assessment of myofilament Ca2+ sensitivity underlying cardiac excitation-contraction coupling. J Vis Exp. doi: 10.3791/54057 Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Chun Li Jin
    • 1
    • 2
  • Yu Na Wu
    • 1
  • Ji Hyun Jang
    • 1
  • Zai Hao Zhao
    • 1
  • Goo Taeg Oh
    • 3
  • Sung Joon Kim
    • 1
  • Yin Hua Zhang
    • 1
    • 2
    • 4
    Email author
  1. 1.Department of Physiology and Biomedical Sciences, Ischemic/hypoxic Disease InstituteSeoul National University, College of MedicineSeoulSouth Korea
  2. 2.Yan Bian University HospitalYanjiChina
  3. 3.Department of Life SciencesEwha Woman’s UniversitySeoulSouth Korea
  4. 4.Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and HealthUniversity of ManchesterManchesterUK

Personalised recommendations